---
figid: PMC9697024__pharmaceuticals-15-01442-g003
pmcid: PMC9697024
image_filename: pharmaceuticals-15-01442-g003.jpg
figure_link: /pmc/articles/PMC9697024/figure/pharmaceuticals-15-01442-f003/
number: Figure 3
figure_title: ''
caption: 'Apigenin has no effects on relative liver weight (A; mg/g, n = 10), serum
  levels of AST (B; U/L, n = 10) and ALT (C; U/L, n = 10), and pathological microstructures
  in HUA mice. Representative images of liver H&E staining (D; ×200, Scale bar: 100
  μm).'
article_title: Apigenin Ameliorates Hyperuricemia and Renal Injury through Regulation
  of Uric Acid Metabolism and JAK2/STAT3 Signaling Pathway.
citation: Tianyuan Liu, et al. Pharmaceuticals (Basel). 2022 Nov;15(11):1442.
year: '2022'

doi: 10.3390/ph15111442
journal_title: Pharmaceuticals
journal_nlm_ta: Pharmaceuticals (Basel)
publisher_name: MDPI

keywords:
- hyperuricemia
- apigenin
- uric acid
- molecular docking
- JAK2/STAT3 signaling
- renal injury

---
